Involvement of GABA systems in acetylcholine release induced by 5-HT3 receptor blockade in slices from rat entorhinal cortex

被引:57
作者
Ramirez, MJ [1 ]
Cenarruzabeitia, E [1 ]
Lasheras, B [1 ]
DelRio, J [1 ]
机构
[1] UNIV NAVARRA,SCH MED,DEPT PHARMACOL,E-31080 PAMPLONA,SPAIN
关键词
ACh release; 5-HT3; receptor; entorhinal cortex; striatum; ondansetron; bicuculline;
D O I
10.1016/0006-8993(95)01471-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The aim of the present study was to examine the role of 5-HT3 receptors in spontaneous and K+-evoked acetylcholine (ACh) release from rat entorhinal cortex and striatal slices. The 5-HT3 receptor antagonists ondansetron and granisetron (0.01-10 mu M) produced a concentration-dependent increase in both spontaneous and K+-evoked [H-3]ACh release in the two brain regions studied. The release of ACh was Ca2+-dependent and tetrodotoxin-sensitive. 5-HT3 receptor agonists, such as 2-methyl-5-HT and 1-phenylbiguanide, at concentrations up to 1 mu M, did not show any intrinsic effect on [H-3]ACh release in both rat brain regions. However, 2-methyl-5-HT, 1 mu M, fully blocked the ondansetron-induced enhancement in both basal and K+-evoked ACh release, suggesting that 5-HT, through 5-HT3 receptor activation, tonically inhibits ACh release. The possible implication of interposed inhibitory systems in ACh release after 5-HT3 receptor blockade was subsequently analyzed. While the effect of ondansetron was not modified by haloperidol or naloxone, the GABA(A) receptor antagonist bicuculline produced a marked potentiation of ACh release in the entorhinal cortex but not in the striatum. The results suggest that in this cortical area 5-HT activates 5-HT3 receptors located on GABAergic neurons which in turn inhibit cholinergic function.
引用
收藏
页码:274 / 280
页数:7
相关论文
共 48 条
[21]  
Del Rio J., 1994, Society for Neuroscience Abstracts, V20, P1554
[22]   THE EFFECT OF ONDANSETRON ON COGNITIVE PERFORMANCE IN THE MARMOSET [J].
DOMENEY, AM ;
COSTALL, B ;
GERRARD, PA ;
JONES, DNC ;
NAYLOR, RJ ;
TYERS, MB .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 38 (01) :169-175
[23]   SEROTONIN INHIBITS ACETYLCHOLINE-RELEASE FROM RAT STRIATUM SLICES - EVIDENCE FOR A PRESYNAPTIC RECEPTOR-MEDIATED EFFECT [J].
GILLET, G ;
AMMOR, S ;
FILLION, G .
JOURNAL OF NEUROCHEMISTRY, 1985, 45 (06) :1687-1691
[24]   BEHAVIORAL PHARMACOLOGY OF 5-HT(3) RECEPTOR ANTAGONISTS - A CRITICAL UPDATE ON THERAPEUTIC POTENTIAL [J].
GREENSHAW, AJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (07) :265-270
[25]   OPIOID RECEPTOR-MEDIATED INHIBITION OF DOPAMINE AND ACETYLCHOLINE-RELEASE FROM SLICES OF RAT NUCLEUS-ACCUMBENS, OLFACTORY TUBERCLE AND FRONTAL-CORTEX [J].
HEIJNA, MH ;
PADT, M ;
HOGENBOOM, F ;
PORTOGHESE, PS ;
MULDER, AH ;
SCHOFFELMEER, ANM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 181 (03) :267-278
[26]   THE SELECTIVE 5-HT3 RECEPTOR ANTAGONIST, WAY100289, ENHANCES SPATIAL MEMORY IN RATS WITH IBOTENATE LESIONS OF THE FOREBRAIN CHOLINERGIC PROJECTION SYSTEM [J].
HODGES, H ;
SOWINSKI, P ;
SINDEN, JD ;
NETTO, CA ;
FLETCHER, A .
PSYCHOPHARMACOLOGY, 1995, 117 (03) :318-332
[28]  
IZUMI J, 1994, J NEUROCHEM, V62, P1804
[29]   INHIBITION OF STRIATAL ACETYLCHOLINE-RELEASE BY ENDOGENOUS SEROTONIN [J].
JACKSON, D ;
STACHOWIAK, MK ;
BRUNO, JP ;
ZIGMOND, MJ .
BRAIN RESEARCH, 1988, 457 (02) :259-266
[30]  
JACOCKS HM, 1992, J PHARMACOL EXP THER, V262, P356